FDA clearance of daily treatment could roil a multibillion-dollar marketJohnson & Johnson won U.S. approval for a daily psoriasis pill that rivals the benefits of injectable medicines and could roil a multibillion-dollar market.The drug, Icotyde, is approved for patients over the age of 12 with moderate to severe plaque psoriasis, J&J said Wednesday. Developed as […]
